Business

Psychedelics and Depression

Havn Life to Cultivate Psilocybin in Jamaica through Hypha Wellness Partnership

Havn Life Sciences is expanding its psilocybin cultivation in Jamaica where the psychedelic mushrooms are legal to grow.

Numinus’ BIG Patent, Mydecine Tackles A $13.6 BILLION Market & Some BUY Ratings! ( NUMI / MYCO)

BIG news for Mydecine (MYCO : NEO) (MYCOF: OTC) and Numinus Wellness (NUMI: NEO) (LKYSF : OTC). But The BIGGER NEWS is that we are finally launching our website:...

MindMed vs. atai Life Sciences (Everything You Need to Know Before Buying MNMD / MMED/ ATAI)

THE MINDMED VS. ATAI discussion you need to hear! Prior to atai's IPO on the NASDAQ stock exchange, we repeatedly said that when atai Life Sciences goes public,...

Psychedelic Business Spotlight: June 25, 2021

,
This week in psychedelic business news: A next-gen psychedelic for stroke care, a major merger, and two more companies list on NEO Exchange.
Former Director of Psychiatric Products at FDA Joins Psychedelic Life Sciences Company Cybin

Former Director of Psychiatric Products at FDA Joins Psychedelic Life Sciences Company Cybin

Former Food and Drug Administration division director Dr. Thomas Laughren has joined the psychedelic life sciences team at Cybin.
Silo Wellness Launches 'Marley One' Brand of Functional and Psychedelic Mushrooms

Silo Wellness Launches ‘Marley One’ Brand of Functional and Psychedelic Mushrooms

The Bob Marley-inspired line of psychedelic and functional mushrooms, Marley One, has officially launched through partner Silo Wellness.

BUY Ratings, New Partnerships & Government Awards ( Mydecine, ENBI, SILO, DMT, BRAXIA, DRUG)

NEW BUY RATINGS, More Partnerships and Government Awards for psychedelic inspired companies! In this episode, we'll take a look at the smaller psychedelic medicine companies such as Mydecine, Entheon...

Red Light Holland CANNABIS Merger, Atai IPO, NUMI Uplists, MindMed & More (TRUFF, atai, Numi, MMED)

LOTS of news happened this week, one of the major ones being Red Light Holland's merger with a CANNABIS Company called Cresco. Other news we discuss in today's...
Atai Life Sciences Valued At More Than $3 Billion After IPO

Atai Life Sciences Valued At More Than $3 Billion After IPO

German psychedelic pharmaceutical company Atai Life Sciences is valued at more than $3 billion after its IPO listing on the Nasdaq.

© 2022 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.